Information sourced from the Australia Government of Health Website
On the 25th January, 2021, the Australian Government announced that the Therapeutic Goods Administration has provisionally approved Pfizer/BioNTech COVID-19 vaccine for use in Australia.
The vaccine has been provisionally approved in Australia for people 16 years of age and over.
Two doses will be required, administered at least 21 days apart.
The first priority groups in Australia will start receiving a vaccine in February. Priority groups include aged care and disability care residents and workers, frontline health care workers, and quarantine and border workers.
The Pfizer vaccine will be delivered at up to 50 hospital sites across Australia, and in residential aged care and disability care facilities.
Researchers and companies across the world are developing potential vaccines for COVID-19. Once vaccines are approved by the Therapeutic Goods Administration (an the regulatory body for therapeutic goods in Australia), the Australian Government has a strategy to deliver them to Australians.
The strategy is aimed at helping to speed up access to safe and effective vaccines or treatment that are available and affordable to all Australians. This will ideally help reduce the health, social and economic impacts of the COVID-19 pandemic.
Australia has entered into 4 separate agreements for the supply of COVID-19 vaccines if they are proved to be safe and effective. More information can be found here on the Australian Government Department of Health's Website.
Finding information about COVID-19 vaccines
Australians are encouraged to rely on reputable sources of information to help them make informed choices and stay up to date.
Reputable information about vaccines is available from:
For more information on the COVID-19 vaccine roll out, please visit the Australian Government Department of Health.